To reduce the risk of developing an active infection and clinical disease in case of contact with Leishmania infantum, through the enhancement of the cell-mediated immune response.
The efficacy of the product has been demonstrated in dogs under multiple natural parasite exposure in zones with high infection pressure.
Control of clinical progression of canine leishmaniosis at early stages of the disease (dogs with low to moderate positive antibody levels and mild clinical signs such as peripheral lymphadenopathy or papular dermatitis).
Active substance: Domperidone. Target species: dog.Indications for use, specifying the target species.
Leisguard 2X60ml